Skip to main content

Advertisement

ADVERTISEMENT

Volume 16 - Issue 11 - November, 2004

08/01/2008
Ramazan Akdemir, MD, Hakan Ozhan, MD, Enver Erbilen, MD, Mehmet Yazici, MD, Sinan Albayrak, MD, Huseyin Gunduz, MD, Cihangir Uyan, MD
Ramazan Akdemir, MD, Hakan Ozhan, MD,...
Multi-center randomized trials indicate that primary angioplasty in acute myocardial infarction (AMI) lowers the rates of death, stroke, recurrent ischemia and re-infarction compared with fibrinolytic therapy.1 For low-risk patients with AMI,...
Multi-center randomized trials indicate that primary angioplasty in acute myocardial infarction (AMI) lowers the rates of death, stroke, recurrent ischemia and re-infarction compared with fibrinolytic therapy.1 For low-risk patients with AMI,...
Multi-center randomized trials...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Over the past decade clinical trials have demonstrated that platelet glycoprotein (GP) IIb/IIIa receptor inhibition dramatically reduces the ischemic complications of percutaneous coronary intervention (PCI).1–6 Currently, there are 3...
Over the past decade clinical trials have demonstrated that platelet glycoprotein (GP) IIb/IIIa receptor inhibition dramatically reduces the ischemic complications of percutaneous coronary intervention (PCI).1–6 Currently, there are 3...
Over the past decade clinical...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
The limitations of coronary angiography for defining the functional significance of intermediately severe lesions are well known. Such angiographic presentations frequently require additional testing to determine their clinical relevance....
The limitations of coronary angiography for defining the functional significance of intermediately severe lesions are well known. Such angiographic presentations frequently require additional testing to determine their clinical relevance....
The limitations of coronary...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Despite the advancements in acute myocardial infarction (AMI) treatment, AMI caused by acute unprotected left main coronary artery (LMCA) occlusion rapidly progresses to cardiogenic shock and death unless there are substantial preexisting...
Despite the advancements in acute myocardial infarction (AMI) treatment, AMI caused by acute unprotected left main coronary artery (LMCA) occlusion rapidly progresses to cardiogenic shock and death unless there are substantial preexisting...
Despite the advancements in...
08/01/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement